CoChat

Regulation of cell lineage specification by the retinoblastoma tumor suppressor

Skapek, S X, Pan, Y-R, Lee, E Y-H P · 2006 · Oncogene

The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.

Abstract

Early studies of the retinoblastoma gene (RB) have uncovered its critical role as a regulator of the G(1)/S cell cycle phase progression. Surprisingly, genetic approaches in mammals and nematodes have also shown RB controls cell lineage specification and aspects of differentiation. The RB gene product accomplishes this by diverse mechanisms such as by interacting with tissue-specific transcription factors, enhancing RNA interference, and modifying chromatin structure. We review recent studies uncovering novel mechanisms by which RB works in several cell lineages and we provide perspectives on how these new findings might relate to RB tumor suppression.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.onc.1209710

Cites

97 of 97 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 35

Metadata

Authors
Skapek, S. X., Pan, Y.-R., & Lee, E. Y.-H. P.
Affiliations
  • St. Jude Children's Research Hospital (US)
  • University of California, Irvine (US)
Corresponding author
  • Skapek, S X
  • Lee, E Y-H P
Venue
Oncogene
Published
2006-08-28
Volume
25
Issue
38
Pages
5268-5276
ISSN
  • 0950-9232 (ISSN-L)
  • 1476-5594
OpenAlex
W2070446251
Cited by
34
References
96
Citations by year
2026: 1 · 2021: 1 · 2019: 1 · 2015: 1 · 2014: 1 · 2013: 1 · 2012: 6
FWCI
0.39
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Oncogene (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords
retinoblastoma protein, cell lineage specification, cell differentiation, G1/S cell cycle progression, tumor suppression, transcription factors, RNA interference, chromatin structure, cell fate determination
MeSH terms
Animals, Cell Cycle, Eye Neoplasms, Humans, Lung, Mammals, Retinoblastoma, Genes, Retinoblastoma, Mice, Knockout, Gene Expression Regulation, Developmental, RNA Interference, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.